These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1206602)
1. Use of bufexamac suppositories in rectal conditions. Samsi AB J Postgrad Med; 1975 Jul; 21(3):131-4. PubMed ID: 1206602 [No Abstract] [Full Text] [Related]
2. [Results of a study of the resorption of bufexamac following rectal administration]. Glowania HJ; Hampl B Z Hautkr; 1988 Mar; 63(3):211. PubMed ID: 3388925 [TBL] [Abstract][Full Text] [Related]
3. [Corticosteroid hormones in suppositories in the treatment of some diseases of the anorectal region]. Iukhbidova ZhM; Shkliar AS; Sergeev VV Sov Med; 1973 Sep; 36(9):100-4. PubMed ID: 4756471 [No Abstract] [Full Text] [Related]
4. [Short-term treatment of "mobile" ano-rectal diseases]. Herr T Z Allgemeinmed; 1969 Sep; 45(26):1214-5. PubMed ID: 5374620 [No Abstract] [Full Text] [Related]
5. [Clinical experience with JO 475 suppositories]. Nora J; Caroli J Med Chir Dig; 1975; 4(1):67-9. PubMed ID: 1160428 [No Abstract] [Full Text] [Related]
6. [A new medicine in proctology: the procto-glyvenol (author's transl)]. Berson I; Geiser JD Schweiz Rundsch Med Prax; 1975 Jan; 64(1):19-22. PubMed ID: 1089251 [No Abstract] [Full Text] [Related]
7. [Multicentric study with the corticoid-free anti-hemorrhoid drug Factu]. Brandes H ZFA (Stuttgart); 1980 Feb; 56(4):284-8. PubMed ID: 7368805 [No Abstract] [Full Text] [Related]
8. [Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases]. Aertgeerts P; Albring M; Klaschka F; Nasemann T; Patzelt-Wenczler R; Rauhut K; Weigl B Z Hautkr; 1985 Feb; 60(3):270-7. PubMed ID: 3158124 [TBL] [Abstract][Full Text] [Related]
9. [Value of a new therapeutic agent, diosmine, in proctology]. Peeters JP Brux Med; 1973 Oct; 53(10):591-4. PubMed ID: 4761153 [No Abstract] [Full Text] [Related]
10. [A new non-steroid anti-inflammatory agent in therapy of osteoarthrosis]. Loizzi P Clin Ter; 1980 Mar; 92(5):497-512. PubMed ID: 7004750 [No Abstract] [Full Text] [Related]
11. [Antiinflammatory treatment of hemorrhoids and anal fissures]. Seghezzi R; Ercoli A; Bordonaro L Minerva Chir; 1968 Dec; 23(24):1296-306. PubMed ID: 5735149 [No Abstract] [Full Text] [Related]
12. [On management of the anal symptom complex]. Yppen H; Richthammer H; Steyrer K Wien Klin Wochenschr; 1967 Feb; 79(7):131-2. PubMed ID: 5592596 [No Abstract] [Full Text] [Related]
13. [Clinical study of topically administered bufexamac in general practice]. Mathieu R Schweiz Rundsch Med Prax; 1971 Nov; 60(47):1577-8. PubMed ID: 5140890 [No Abstract] [Full Text] [Related]
14. [Treatment of anus diseases with a corticoid-free drug combination]. Röseler P ZFA (Stuttgart); 1977 May; 53(13):748-50. PubMed ID: 560091 [No Abstract] [Full Text] [Related]
15. [Contact allergies caused by bufexamac]. Geier J; Fuchs T Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420 [TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of bufexamac in symptomatic treatment of hemorrhoids: cooperative study]. Vigoni M Brux Med; 1972 Oct; 52(10):735-9. PubMed ID: 4656195 [No Abstract] [Full Text] [Related]